CL2014000298A1 - Metodo para producir una suspension de aglomerados de nanoparticulas de metal recubiertas con alcoxisilano magnetico; suspension de aglomerados; composicion que comprende dichos aglomerados; y medicamento. - Google Patents

Metodo para producir una suspension de aglomerados de nanoparticulas de metal recubiertas con alcoxisilano magnetico; suspension de aglomerados; composicion que comprende dichos aglomerados; y medicamento.

Info

Publication number
CL2014000298A1
CL2014000298A1 CL2014000298A CL2014000298A CL2014000298A1 CL 2014000298 A1 CL2014000298 A1 CL 2014000298A1 CL 2014000298 A CL2014000298 A CL 2014000298A CL 2014000298 A CL2014000298 A CL 2014000298A CL 2014000298 A1 CL2014000298 A1 CL 2014000298A1
Authority
CL
Chile
Prior art keywords
agglomerates
suspension
medication
producing
composition
Prior art date
Application number
CL2014000298A
Other languages
English (en)
Inventor
Norbert Waldofner
Andreas Jordan
Original Assignee
Magforce Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Magforce Ag filed Critical Magforce Ag
Publication of CL2014000298A1 publication Critical patent/CL2014000298A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0052—Thermotherapy; Hyperthermia; Magnetic induction; Induction heating therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F41/00—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties
    • H01F41/14—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates
    • H01F41/16—Apparatus or processes specially adapted for manufacturing or assembling magnets, inductances or transformers; Apparatus or processes specially adapted for manufacturing materials characterised by their magnetic properties for applying magnetic films to substrates the magnetic material being applied in the form of particles, e.g. by serigraphy, to form thick magnetic films or precursors therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Power Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Manufacturing & Machinery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Iron (AREA)
  • Soft Magnetic Materials (AREA)
  • Hard Magnetic Materials (AREA)
  • Powder Metallurgy (AREA)
  • Electrotherapy Devices (AREA)
  • Manufacture Of Metal Powder And Suspensions Thereof (AREA)
CL2014000298A 2011-08-10 2014-02-06 Metodo para producir una suspension de aglomerados de nanoparticulas de metal recubiertas con alcoxisilano magnetico; suspension de aglomerados; composicion que comprende dichos aglomerados; y medicamento. CL2014000298A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161522217P 2011-08-10 2011-08-10

Publications (1)

Publication Number Publication Date
CL2014000298A1 true CL2014000298A1 (es) 2014-07-18

Family

ID=46690467

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014000298A CL2014000298A1 (es) 2011-08-10 2014-02-06 Metodo para producir una suspension de aglomerados de nanoparticulas de metal recubiertas con alcoxisilano magnetico; suspension de aglomerados; composicion que comprende dichos aglomerados; y medicamento.

Country Status (21)

Country Link
US (2) US9408912B2 (es)
EP (2) EP2742515B1 (es)
JP (1) JP5844902B2 (es)
KR (1) KR101513841B1 (es)
CN (1) CN104620334B (es)
AU (1) AU2012292554B2 (es)
BR (1) BR112014002726A8 (es)
CA (1) CA2844774C (es)
CL (1) CL2014000298A1 (es)
CO (1) CO6940414A2 (es)
DE (1) DE202012012795U1 (es)
DK (1) DK2742515T3 (es)
ES (2) ES2582283T3 (es)
HK (1) HK1210317A1 (es)
IL (1) IL230799A (es)
MX (1) MX358576B (es)
PL (2) PL3038115T3 (es)
PT (1) PT2742515T (es)
RU (1) RU2622025C2 (es)
WO (1) WO2013020701A2 (es)
ZA (1) ZA201400564B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015188190A1 (en) * 2014-06-06 2015-12-10 The Regents Of The University Of California Sunlight reflecting materials and methods of fabrication
WO2021152136A1 (en) 2020-01-31 2021-08-05 Magforce Ag Paste comprising magnetic alkoxysilane-coated metal containing nanoparticles
DE102020116859A1 (de) 2020-06-26 2021-12-30 Pharma Development Holding Gmbh Liposomen
KR102503870B1 (ko) * 2021-01-08 2023-02-24 한밭대학교 산학협력단 온열치료용 산화철 나노 클러스터 및 이의 제조 방법

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3945945A (en) 1971-05-10 1976-03-23 Norton Company High surface area alumina bodies
US4169912A (en) 1975-10-02 1979-10-02 Dynamit Nobel Aktiengesellschaft Iron oxide magnetic pigments for the production of magnetic coatings
DE2543962A1 (de) 1975-10-02 1977-04-14 Dynamit Nobel Ag Verbesserte eisenoxid-magnetpigmente fuer die herstellung von magnetschichten
CA1254238A (en) 1985-04-30 1989-05-16 Alvin P. Gerk Process for durable sol-gel produced alumina-based ceramics, abrasive grain and abrasive products
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
US4827945A (en) 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
FR2618084B1 (fr) 1987-07-15 1989-11-10 Rhone Poulenc Chimie Microspheres magnetisables a base de polysiloxane, leur procede de preparation et leur application en biologie
EP0381742B1 (en) 1988-08-04 1996-06-19 Advanced Magnetics Incorporated Receptor mediated endocytosis type mri contrast agents
EP0451152B1 (en) 1988-10-13 1993-08-25 Tioxide Specialties Limited Ceramic powders
US5460831A (en) 1990-06-22 1995-10-24 The Regents Of The University Of California Targeted transfection nanoparticles
US5462751A (en) 1990-06-22 1995-10-31 The Regeants Of The University Of California Biological and pharmaceutical agents having a nanomeric biodegradable core
DE4026978A1 (de) 1990-08-25 1992-02-27 Bayer Ag Auf traegern angebrachte ein- oder mehrlagige schichtelemente und ihre herstellung
US5616311A (en) 1991-01-15 1997-04-01 Hemosphere, Inc. Non-crosslinked protein particles for therapeutic and diagnostic use
JP3389611B2 (ja) 1992-02-28 2003-03-24 戸田工業株式会社 無機物粒子含有樹脂複合球状物粉体
DE4212633A1 (de) 1992-04-15 1993-10-21 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung oberflächenmodifizierter nanoskaliger keramischer Pulver
CA2135769A1 (en) 1992-05-29 1993-12-09 Kent C. Cochrum Coated transplant and method for making same
US5654004A (en) 1992-11-06 1997-08-05 Hisamitsu Pharmaceutical Co., Inc. Oral pharmaceutical preparation releasable in the lower digestive tract
US5401313A (en) 1993-02-10 1995-03-28 Harcros Pigments, Inc. Surface modified particles and method of making the same
US5916539A (en) 1993-03-02 1999-06-29 Silica Gel Ges. M.B.H. Superparamagnetic particles, process for producing the same and their use
JPH06270155A (ja) 1993-03-23 1994-09-27 Sekisui Chem Co Ltd 型内被覆用樹脂組成物
US5547748A (en) 1994-01-14 1996-08-20 Sri International Carbon nanoencapsulates
FR2721615A1 (fr) 1994-06-24 1995-12-29 Rhone Poulenc Chimie Procédé de préparation de particules d'oxyde métallique organophiles.
PL318099A1 (en) 1994-07-07 1997-05-12 Chiron Diagnostics Corp Very fine magnetic particles of metal oxides, methods of obtaining them and their applications
JP3436760B2 (ja) 1994-07-27 2003-08-18 ハーバート ピルグリム 超常磁性粒子
US6103379A (en) 1994-10-06 2000-08-15 Bar-Ilan University Process for the preparation of microspheres and microspheres made thereby
GB9420390D0 (en) 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
US5540959A (en) 1995-02-21 1996-07-30 Howard J. Greenwald Process for preparing a coated substrate
DE19515820A1 (de) 1995-04-29 1996-10-31 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung schwach agglomerierter nanoskaliger Teilchen
JPH09646A (ja) * 1995-06-16 1997-01-07 Toshiba Corp 治療用誘導加熱装置
US6022500A (en) 1995-09-27 2000-02-08 The United States Of America As Represented By The Secretary Of The Army Polymer encapsulation and polymer microsphere composites
US5695900A (en) * 1995-12-21 1997-12-09 Colorado School Of Mines Surface treatment of magnetic particles for use in reprographic processes
US5922403A (en) 1996-03-12 1999-07-13 Tecle; Berhan Method for isolating ultrafine and fine particles
DE19612001A1 (de) 1996-03-18 1997-09-25 Silica Gel Gmbh Adsorptions Te Superparamagnetische Teilchen mit vergrößerter R¶1¶-Relaxivität, Verfahren zur Herstellung und deren Verwendung
DE19614136A1 (de) 1996-04-10 1997-10-16 Inst Neue Mat Gemein Gmbh Verfahren zur Herstellung agglomeratfreier nanoskaliger Eisenoxidteilchen mit hydrolysebeständigem Überzug
US5922537A (en) 1996-11-08 1999-07-13 N.o slashed.AB Immunoassay, Inc. Nanoparticles biosensor
DE19716732C2 (de) 1997-03-07 1999-03-25 Max Delbrueck Centrum Spezifische Magnetosomen, Verfahren zu ihrer Herstellung und ihre Verwendung
EP0971692B1 (de) 1997-03-07 2003-03-05 Max-Delbrück-Centrum Für Molekulare Medizin Spezifische magnetosomen, verfahren zu ihrer herstellung und ihre verwendung
WO1998053372A1 (de) * 1997-05-23 1998-11-26 Agfa Gevaert Ag Beschichtete partikel
DE19726282A1 (de) 1997-06-20 1998-12-24 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen mit einem von mindestens zwei Schalen umgebenen eisenoxid-haltigen Kern
DE19912502A1 (de) 1999-03-19 2000-09-21 Inst Neue Mat Gemein Gmbh Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung
DE19921088C2 (de) 1999-04-30 2003-08-07 Magforce Applic Gmbh Stent zur Offenhaltung gangartiger Strukturen
DE19940220B4 (de) 1999-08-19 2007-05-03 Magforce Nanotechnologies Ag Medizinisches Präparat zur Behandlung von Arthrose, Arthritis und anderen rheumatischen Gelenkerkrankungen
US6548264B1 (en) 2000-05-17 2003-04-15 University Of Florida Coated nanoparticles
US20030092029A1 (en) 2001-06-06 2003-05-15 Lee Josephson Magneitc-nanoparticle conjugates and methods of use
US7731648B2 (en) 2001-07-25 2010-06-08 Aduro Biotech Magnetic nanoscale particle compositions, and therapeutic methods related thereto
US20040156852A1 (en) 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
DE10153639A1 (de) * 2001-10-31 2003-05-22 Inst Neue Mat Gemein Gmbh Superparamagnetisches Eisenoxid enthaltende Kompositpartikel
DE10261406A1 (de) 2002-12-30 2004-07-15 Sustech Gmbh & Co. Kg Verfahren zur Herstellung oberflächenbeschichteter nanoskaliger Teilchen und von Suspensionen, die diese enthalten
US20040156846A1 (en) 2003-02-06 2004-08-12 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles using L6 antibodies
DE10331439B3 (de) 2003-07-10 2005-02-03 Micromod Partikeltechnologie Gmbh Magnetische Nanopartikel mit verbesserten Magneteigenschaften
US20050119725A1 (en) 2003-04-08 2005-06-02 Xingwu Wang Energetically controlled delivery of biologically active material from an implanted medical device
FR2855315B1 (fr) 2003-05-23 2005-08-19 Centre Nat Rech Scient Ferrofluides stables en milieu neutre et ferrofluides modifies obtenus par modification de la surface des particules de ces ferrofluides
US8651113B2 (en) 2003-06-18 2014-02-18 Swr&D Inc. Magnetically responsive nanoparticle therapeutic constructs and methods of making and using
US7531149B2 (en) 2003-10-14 2009-05-12 The Board Of Trustees Of The University Of Arkansas Synthetic control of metal oxide nanocrystal sizes and shapes
US20050090732A1 (en) 2003-10-28 2005-04-28 Triton Biosystems, Inc. Therapy via targeted delivery of nanoscale particles
DE102004052533A1 (de) 2004-10-15 2006-05-04 Mykhaylyk, Olga, Dr. Magnetische Partikel zur Verwendung in Therapie und Diagnostik
WO2006057467A1 (en) 2004-11-26 2006-06-01 Seoul National University Industry Foundation Method for large-scale production of monodisperse nanoparticles
US7462446B2 (en) 2005-03-18 2008-12-09 University Of Washington Magnetic nanoparticle compositions and methods
DE102005016873A1 (de) 2005-04-12 2006-10-19 Magforce Nanotechnologies Ag Nanopartikel-Wirstoff-Konjugate
WO2006125452A1 (en) 2005-05-23 2006-11-30 Universite De Geneve Injectable superparamagnetic nanoparticles for treatment by hyperthermia and use for forming an hyperthermic implant
GB0512374D0 (en) 2005-06-17 2005-07-27 Nanosphere Ltd Coated microspheres
DE102005039579B4 (de) * 2005-08-19 2022-06-30 Magforce Ag Verfahren zur Einschleusung von therapeutischen Substanzen in Zellen
US20070269380A1 (en) 2005-10-11 2007-11-22 Washington, University Of Methotrexate-modified nanoparticles and related methods
DE102005059751A1 (de) 2005-12-09 2007-06-14 Ferropharm Gmbh Forschungslabor Wässrige Dispersion von superparamagnetischen Eindomänenteilchen, deren Herstellung und Verwendung zur Diagnose und Therapie
JP2008019202A (ja) * 2006-07-12 2008-01-31 Koichi Jinbo メラノーマ標的温熱免疫療法治療剤
WO2008014623A1 (fr) 2006-07-31 2008-02-07 Ecole Polytechnique Federale De Lausanne (Epfl) Nanoparticules a noyau metallique recouvert de silice
TWI321133B (en) 2006-08-01 2010-03-01 Univ Kaohsiung Medical Folate-receptor-targeting iron oxide nanoparticles coated with poly(ethylene glycol)
RU2373957C2 (ru) * 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
EP1935436A1 (en) 2006-12-12 2008-06-25 Dublin City University Nanoparticle clusters and methods for forming same
JP5057208B2 (ja) * 2006-12-20 2012-10-24 株式会社豊田中央研究所 磁性材料の製造方法
US20110104073A1 (en) 2007-01-18 2011-05-05 Qi Zeng Iron/Iron Oxide Nanoparticle and Use Thereof
EP1952919B1 (en) 2007-02-02 2013-04-24 FUJIFILM Corporation Magnetic nanoparticles and aqueous colloid composition containing the same
EP2242805A1 (en) 2008-01-04 2010-10-27 Sparkxis B.V. Surface modification of metal oxide nanoparticles
DE102008003615A1 (de) 2008-01-09 2009-07-16 Magforce Nanotechnologies Ag Magnetische Transducer
US20100284924A1 (en) 2008-01-23 2010-11-11 The Regents Of The University Of California Nano-devices having impellers for capture and release of molecules
DE102008008522A1 (de) * 2008-02-11 2009-08-13 Magforce Nanotechnologies Ag Implantierbare Nanopartikel-enthaltende Produkte
US20090226376A1 (en) 2008-03-05 2009-09-10 General Electric Company Novel Mixed Ligand Core/Shell Iron Oxide Nanoparticles for Inflammation Imaging
WO2010062615A1 (en) 2008-10-27 2010-06-03 Board Of Trustees Of The University Of Arkansas Metallic nanoparticles with coated shells and applications of same
GB2472446A (en) 2009-08-07 2011-02-09 Ct Fuer Angewandte Nanotechnologie Metal oxide particles coated with polyethylene glycol and their synthesis
DE102009058769A1 (de) 2009-12-16 2011-06-22 MagForce Nanotechnologies AG, 10589 Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
EP2383374A1 (en) 2010-04-29 2011-11-02 BASF Corporation Nano-particles containing carbon and a ferromagnetic metal or alloy
JP2013526616A (ja) 2010-05-26 2013-06-24 ザ ジェネラル ホスピタル コーポレイション 磁性ナノ粒子
CN102971014A (zh) 2010-06-29 2013-03-13 皇家飞利浦电子股份有限公司 用于磁性粒子成像(mpi)的高性能铁氧化物粒子示踪剂的合成
TW201247225A (en) 2011-05-17 2012-12-01 Univ Nat Chiao Tung Drug carrier with thermal sensitivity, manufacturing method thereof, and use of the same as NMR contrast agent
US10220004B2 (en) 2011-07-14 2019-03-05 The Regents Of The University Of California Method of controlled delivery using sub-micron-scale machines

Also Published As

Publication number Publication date
IL230799A (en) 2017-12-31
BR112014002726A8 (pt) 2017-06-20
JP2014532291A (ja) 2014-12-04
ES2807209T3 (es) 2021-02-22
EP3038115B1 (en) 2020-05-06
ZA201400564B (en) 2015-12-23
PL3038115T3 (pl) 2020-11-02
CA2844774A1 (en) 2013-02-14
RU2622025C2 (ru) 2017-06-08
AU2012292554B2 (en) 2014-10-30
PT2742515T (pt) 2016-07-14
RU2014109015A (ru) 2015-09-20
BR112014002726A2 (pt) 2017-06-13
EP2742515A2 (en) 2014-06-18
KR101513841B1 (ko) 2015-04-24
US9962442B2 (en) 2018-05-08
CN104620334A (zh) 2015-05-13
DK2742515T3 (en) 2016-06-13
WO2013020701A3 (en) 2013-04-04
MX358576B (es) 2018-08-27
DE202012012795U1 (de) 2013-11-21
CN104620334B (zh) 2016-10-26
EP3038115A1 (en) 2016-06-29
CO6940414A2 (es) 2014-05-09
PL2742515T3 (pl) 2017-03-31
US20140154324A1 (en) 2014-06-05
JP5844902B2 (ja) 2016-01-20
EP2742515B1 (en) 2016-04-13
US20160367673A1 (en) 2016-12-22
WO2013020701A2 (en) 2013-02-14
AU2012292554A1 (en) 2013-05-02
KR20140037290A (ko) 2014-03-26
US9408912B2 (en) 2016-08-09
IL230799A0 (en) 2014-03-31
CA2844774C (en) 2019-08-27
HK1210317A1 (zh) 2016-04-15
ES2582283T3 (es) 2016-09-12
MX2014001186A (es) 2014-05-13

Similar Documents

Publication Publication Date Title
EP2990382A4 (en) Magnetic iron oxide nanoparticle powder, process for producing same, thin film of magnetic iron oxide nanoparticles comprising said magnetic iron oxide nanoparticle powder, and process for producing same
HK1204593A1 (en) Method for producing a metal nanoparticle dispersion, metal nanoparticle dispersion, and use of said metal nanoparticle dispersion
EP2671655A4 (en) Coated metal microparticle and manufacturing method thereof
EP2704902A4 (en) MAGNETIC GRAPHIC TYPE NANO PARTICLES OR GRAPHIC MICRO PARTICLES AND METHODS OF MANUFACTURE AND USES THEREOF
EP2742415A4 (en) PULLING AND STORING OBJECTS BETWEEN APPLICATIONS
EP2667990A4 (en) STABILIZED METAL NANOPARTICLES AND MANUFACTURING METHOD THEREFOR
EP2862889A4 (en) METHOD FOR PRODUCING A SOLID POLYMETHYLALUMINOXANE COMPOSITION WITH SMALL PARTIAL DIAMETER
EP2684117A4 (en) METHOD AND SYSTEM FOR UNIFORM INFORMATION REPRESENTATION AND ITS APPLICATION
GB201410698D0 (en) Magnetic particle having a highly reflective protective film, and method for manufacturing same
EP2677316A4 (en) STREPTAVIDINE-RELATED MAGNETIC PARTICLES AND METHOD FOR THE PRODUCTION THEREOF
SG10201401574VA (en) Metal compound coated colloidal particles process for making and use therefor
TWI560308B (en) Particle reducing method and film deposition method
SG10201706984QA (en) Magnetic-disk glass substrate, magnetic disk and method for manufacturing magnetic-disk glass substrate
EP3043904A4 (en) Manufacture of magnetic particles
EP2754692A4 (en) RESIN PARTICLE, PROCESS FOR ITS MANUFACTURE AND ITS USE
EP2581152A4 (en) Method for producing core-shell magnetic alloy nanoparticle
BR112014007031A2 (pt) partícula de nano-estrutura auto-montável e método para preparação
HK1198740A1 (en) Continuous flow production of gelatin nanoparticles
CL2014000298A1 (es) Metodo para producir una suspension de aglomerados de nanoparticulas de metal recubiertas con alcoxisilano magnetico; suspension de aglomerados; composicion que comprende dichos aglomerados; y medicamento.
PL395002A1 (pl) Hybrydowy material zawierajacy nanoczastki srebra, sposób wytwarzania materialu hybrydowego oraz jego zastosowanie
EP2575158A4 (en) SOURCE OF PARTICLES AND PROCESS FOR PRODUCTION THEREOF
PT2570120T (pt) Partículas revestidas e processo de produção de partículas revestidas
SG11201405080XA (en) Method for manufacturing magnetic-disk glass substrate and method for manufacturing magnetic disk
HK1225644A1 (zh) 納米粒子和納米粒子組合物以及用於生產納米粒子和納米粒子組合物的方法
EP3037498A4 (en) Fluorescent particle comprising gold nanoparticles and method for manufacturing same